Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rivaroxaban versus warfarin in Japanese patients with non-valvular atrial fibrillation in relation to hypertension: a subgroup analysis of the J-ROCKET AF trial.
Matsumoto M, Hori M, Tanahashi N, Momomura S, Uchiyama S, Goto S, Izumi T, Koretsune Y, Kajikawa M, Kato M, Ueda H, Iekushi K, Yamanaka S, Tajiri M; J-ROCKET AF Study Investigators. Matsumoto M, et al. Among authors: uchiyama s. Hypertens Res. 2014 May;37(5):457-62. doi: 10.1038/hr.2014.1. Epub 2014 Jan 30. Hypertens Res. 2014. PMID: 24477179 Clinical Trial.
Risk factor profile and management of cerebrovascular patients in the REACH Registry.
Röther J, Alberts MJ, Touzé E, Mas JL, Hill MD, Michel P, Bhatt DL, Aichner FT, Goto S, Matsumoto M, Ohman EM, Okada Y, Uchiyama S, D'Agostino R, Hirsch AT, Wilson PW, Steg PG; REACH Registry Investigators. Röther J, et al. Among authors: uchiyama s. Cerebrovasc Dis. 2008;25(4):366-74. doi: 10.1159/000120687. Epub 2008 Mar 13. Cerebrovasc Dis. 2008. PMID: 18337635
Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study.
Toyoda K, Yasaka M, Iwade K, Nagata K, Koretsune Y, Sakamoto T, Uchiyama S, Gotoh J, Nagao T, Yamamoto M, Takahashi JC, Minematsu K; Bleeding with Antithrombotic Therapy (BAT) Study Group. Toyoda K, et al. Among authors: uchiyama s. Stroke. 2008 Jun;39(6):1740-5. doi: 10.1161/STROKEAHA.107.504993. Epub 2008 Apr 3. Stroke. 2008. PMID: 18388341
Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.
Goto S, Bhatt DL, Röther J, Alberts M, Hill MD, Ikeda Y, Uchiyama S, D'Agostino R, Ohman EM, Liau CS, Hirsch AT, Mas JL, Wilson PW, Corbalán R, Aichner F, Steg PG; REACH Registry Investigators. Goto S, et al. Among authors: uchiyama s. Am Heart J. 2008 Nov;156(5):855-63, 863.e2. doi: 10.1016/j.ahj.2008.06.029. Epub 2008 Sep 23. Am Heart J. 2008. PMID: 19061698
Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry.
Uchiyama S, Goto S, Matsumoto M, Nagai R, Origasa H, Yamazaki T, Shigematsu H, Shimada K, Yamada N, Bhatt DL, Steg PG, Ikeda Y; REduction of Atherothrombosis for Continued Health Registry Investigators. Uchiyama S, et al. J Neurol Sci. 2009 Dec 15;287(1-2):45-51. doi: 10.1016/j.jns.2009.09.011. Epub 2009 Oct 7. J Neurol Sci. 2009. PMID: 19815240
Sex-related differences in the risk factor profile and medications of patients with atrial fibrillation recruited in J-TRACE.
Inoue H, Nozawa T, Hirai T, Goto S, Origasa H, Shimada K, Uchiyama S, Hirabayashi T, Koretsune Y, Ono S, Hasegawa T, Sasagawa Y, Kaneko Y, Ikeda Y; J-TRACE Investigators. Inoue H, et al. Among authors: uchiyama s. Circ J. 2010 Apr;74(4):650-4. doi: 10.1253/circj.cj-09-0802. Epub 2010 Feb 20. Circ J. 2010. PMID: 20173301 Free article.
1,309 results